Flow characterization of a pharmaceutical excipient using the shear cell method
The powders used in the production of solid dosage forms must have ability to flow that allows their industrial processing. Although this property has been studied for most of the powders, in this study non-expected flow behaviors were observed for the model excipient used, Microcrystalline Cellulose (MCC). Several fractions with different sizes were fractioned by sieving of the model excipient and its flow behaviors were analyzed by different methods. The shear cell results showed an increase of the flowability index (ffc) with the increase of the particle size and consolidation stress. Some related information has been referenced in the literature, however, in this work it was shown for different size fractions that the ffc decreased above a certain consolidation stress value (2000-4000 N/m2). The explanation of this phenomenon is based on the increase of cohesion. Furthermore, it was also observed that the fractions with sizes between 125-180 µm present a ffc higher than bulk powder (FTotal) with similar percentile (DV50) indicating that this index is dependent on the size of the particles and also on its size distribution range. Thus, it can be affirmed that more homogeneous samples in size and with a narrower distribution present a better ffc.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Pharmaceutical development and technology - 25(2020), 2 vom: 17. Feb., Seite 237-244 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Salústio, Paulo José [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9004-34-6 |
|---|
| Anmerkungen: |
Date Completed 04.06.2020 Date Revised 04.06.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10837450.2019.1688348 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30321970X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30321970X | ||
| 003 | DE-627 | ||
| 005 | 20231225112352.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10837450.2019.1688348 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1010.xml |
| 035 | |a (DE-627)NLM30321970X | ||
| 035 | |a (NLM)31718375 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salústio, Paulo José |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Flow characterization of a pharmaceutical excipient using the shear cell method |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.06.2020 | ||
| 500 | |a Date Revised 04.06.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The powders used in the production of solid dosage forms must have ability to flow that allows their industrial processing. Although this property has been studied for most of the powders, in this study non-expected flow behaviors were observed for the model excipient used, Microcrystalline Cellulose (MCC). Several fractions with different sizes were fractioned by sieving of the model excipient and its flow behaviors were analyzed by different methods. The shear cell results showed an increase of the flowability index (ffc) with the increase of the particle size and consolidation stress. Some related information has been referenced in the literature, however, in this work it was shown for different size fractions that the ffc decreased above a certain consolidation stress value (2000-4000 N/m2). The explanation of this phenomenon is based on the increase of cohesion. Furthermore, it was also observed that the fractions with sizes between 125-180 µm present a ffc higher than bulk powder (FTotal) with similar percentile (DV50) indicating that this index is dependent on the size of the particles and also on its size distribution range. Thus, it can be affirmed that more homogeneous samples in size and with a narrower distribution present a better ffc | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Flowing | |
| 650 | 4 | |a excipient | |
| 650 | 4 | |a flow index | |
| 650 | 4 | |a shear cell | |
| 650 | 4 | |a sieving | |
| 650 | 7 | |a Excipients |2 NLM | |
| 650 | 7 | |a Powders |2 NLM | |
| 650 | 7 | |a Cellulose |2 NLM | |
| 650 | 7 | |a 9004-34-6 |2 NLM | |
| 650 | 7 | |a microcrystalline cellulose |2 NLM | |
| 650 | 7 | |a OP1R32D61U |2 NLM | |
| 700 | 1 | |a Inácio, Cláudia |e verfasserin |4 aut | |
| 700 | 1 | |a Nunes, Telmo |e verfasserin |4 aut | |
| 700 | 1 | |a Sousa E Silva, José Paulo |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Paulo Cardoso |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d 1998 |g 25(2020), 2 vom: 17. Feb., Seite 237-244 |w (DE-627)NLM094740194 |x 1097-9867 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2020 |g number:2 |g day:17 |g month:02 |g pages:237-244 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10837450.2019.1688348 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2020 |e 2 |b 17 |c 02 |h 237-244 | ||